Notes - Segment Information, Etc.

OncoTherapy Science, Inc. - Filing #7253509

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
750,048,000 JPY
747,057,000 JPY
2,991,000 JPY
750,048,000 JPY
JPY
610,118,000 JPY
JPY
610,118,000 JPY
427,000 JPY
609,690,000 JPY
Transactions with other segments
294,000 JPY
JPY
294,000 JPY
JPY
-294,000 JPY
270,000 JPY
-270,000 JPY
JPY
270,000 JPY
JPY
Other items
Depreciation
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Increase in property, plant and equipment and intangible assets
279,000 JPY
279,000 JPY
JPY
279,000 JPY
JPY
154,564,000 JPY
JPY
154,564,000 JPY
JPY
154,564,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.